Get the Stockscreener App
4.07
0.25%
-0.010
After Hours:
4.01
-0.06
-1.47%
Prime Medicine Inc stock is traded at $4.07, with a volume of 2.70M.
It is down -0.25% in the last 24 hours and up +17.63% over the past month.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
See More
Previous Close:
$4.08
Open:
$4.125
24h Volume:
2.70M
Relative Volume:
0.66
Market Cap:
$547.72M
Revenue:
-
Net Income/Loss:
$-217.44M
P/E Ratio:
-1.8756
EPS:
-2.17
Net Cash Flow:
$-205.20M
1W Performance:
+9.41%
1M Performance:
+17.63%
6M Performance:
+113.09%
1Y Performance:
+0.49%
1-Day Range:
$3.9401
$4.125
1-Week Range:
$3.6801
$4.18
52-Week Range:
$1.11
$5.17
Prime Medicine Inc Stock (PRME) Company Profile
Name
Prime Medicine Inc
Sector
Industry
Phone
617-465-0013
Address
60 FIRST ST., CAMBRIDGE
Compare PRME with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRME
Prime Medicine Inc
|
4.07 | 693.49M | 0 | -217.44M | -205.20M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Prime Medicine Inc Stock (PRME) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Downgrade | Citigroup | Buy → Neutral |
| May-20-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-20-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-10-24 | Initiated | JMP Securities | Mkt Outperform |
| May-20-24 | Initiated | H.C. Wainwright | Buy |
| May-16-24 | Upgrade | Citigroup | Neutral → Buy |
| Apr-22-24 | Initiated | Chardan Capital Markets | Buy |
| Apr-08-24 | Initiated | TD Cowen | Buy |
| Apr-03-24 | Initiated | Wedbush | Outperform |
| Jan-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-08-23 | Initiated | Citigroup | Neutral |
| Oct-09-23 | Initiated | BMO Capital Markets | Outperform |
| Jul-31-23 | Initiated | Guggenheim | Buy |
| Apr-18-23 | Initiated | Stifel | Buy |
| Nov-14-22 | Initiated | Goldman | Neutral |
| Nov-14-22 | Initiated | JP Morgan | Overweight |
| Nov-14-22 | Initiated | Jefferies | Buy |
| Nov-14-22 | Initiated | Morgan Stanley | Equal-Weight |
View All
Prime Medicine Inc Stock (PRME) Latest News
Citi Downgrades Prime Medicine (PRME) to Neutral, Cuts PT to $1.50 Due to Market Uncertainty - MSN
Is Prime Medicine Inc. backed by strong institutional buyingStop Loss & Free High Accuracy Swing Entry Alerts - Lancaster City Council
Prime Medicine Unveils New Prime Editing Advancements - TipRanks
Prime Medicine Inc. Breaks Losing Streak — Is the Trend ReversingJuly 2025 Institutional & Smart Allocation Stock Tips - beatles.ru
Prime Medicine (NASDAQ:PRME) Stock Price Down 3.7% After Analyst Downgrade - MarketBeat
What is Prime Medicine Inc.’s market position2025 Macro Impact & Advanced Swing Trade Entry Alerts - 뉴스영
Best data tools to analyze Prime Medicine Inc. stock2025 Bull vs Bear & Stock Portfolio Risk Control - Newser
Can Prime Medicine Inc. disrupt its industryAnalyst Upgrade & Step-by-Step Trade Execution Guides - خودرو بانک
Is Prime Medicine Inc. stock reversal real or fakeJuly 2025 Short Interest & Low Risk High Win Rate Picks - Newser
Why is Prime Medicine Inc. stock going up2025 Trade Ideas & Safe Entry Point Identification - خودرو بانک
Analyzing Prime Medicine Inc. with multi timeframe chartsProfit Target & Consistent Profit Alerts - Newser
How to read the order book for Prime Medicine Inc.CEO Change & Weekly Watchlist for Hot Stocks - Newser
How moving averages guide Prime Medicine Inc. tradingJuly 2025 Technicals & High Conviction Buy Zone Alerts - Newser
What data driven models say about Prime Medicine Inc.’s futureStock Surge & Risk Managed Investment Strategies - Newser
What’s Prime Medicine Inc.’s historical returnIPO Watch & Precise Buy Zone Tips - khodrobank.com
Is a relief rally coming for Prime Medicine Inc. holdersWeekly Stock Summary & Expert Verified Movement Alerts - Newser
Market reaction to Prime Medicine Inc.’s recent news2025 Geopolitical Influence & Smart Money Movement Tracker - Newser
Is Prime Medicine Inc. forming a breakout pattern2025 Top Decliners & Low Risk Entry Point Guides - خودرو بانک
Is this a good reentry point in Prime Medicine Inc.Earnings Summary Report & AI Driven Price Predictions - Newser
Will Prime Medicine Inc. stock go up soonProfit Target & Technical Pattern Based Signals - Newser
Strategies to average down on Prime Medicine Inc.Trade Analysis Report & Risk Controlled Daily Trade Plans - Newser
How hedge fund analytics apply to Prime Medicine Inc. stockMarket Risk Analysis & Reliable Price Action Trade Plans - Newser
Visual trend scoring systems applied to Prime Medicine Inc.July 2025 Sentiment & AI Driven Stock Price Forecasts - Newser
What is Prime Medicine Inc. s revenue forecastGap Down & Verified Swing Trading Watchlist - خودرو بانک
Prime Medicine, Inc. shares rise 7.85% intraday after presenting at Citi's Biopharma Back to School event. - AInvest
Can a trend reversal in Prime Medicine Inc. lead to recovery2025 Winners & Losers & Comprehensive Market Scan Insights - Newser
Can machine learning forecast Prime Medicine Inc. recoveryMarket Movers & Consistent Growth Equity Picks - Newser
Will Prime Medicine Inc. continue its uptrendMarket Trend Report & Consistent Income Trade Ideas - Newser
What moving averages say about Prime Medicine Inc.Portfolio Risk Report & Reliable Entry Point Trade Alerts - Newser
Multi asset correlation models including Prime Medicine Inc.2025 Volatility Report & Community Shared Stock Ideas - Newser
Prime Medicine to Participate in Upcoming Investor Conferences - 富途牛牛
Can volume confirm reversal in Prime Medicine Inc.July 2025 Selloffs & Intraday High Probability Setup Alerts - Newser
Evaluating Prime Medicine Inc. with trendline analysis2025 Year in Review & Risk Controlled Swing Trade Alerts - Newser
Prime Medicine Inc. stock trendline breakdownWeekly Stock Report & Low Volatility Stock Recommendations - Newser
Prime Medicine Inc. Recovery Hinges on Volume BreakoutJuly 2025 Action & High Return Trade Opportunity Guides - beatles.ru
Can Prime Medicine Inc. reach resistance levels soonJuly 2025 Intraday Action & Weekly Sector Rotation Insights - خودرو بانک
Is Prime Medicine Inc. exposed to political riskMarket Growth Summary & High Accuracy Swing Entry Alerts - خودرو بانک
Is Prime Medicine Inc. stock a good pick for beginnersEarnings Trend Report & Reliable Price Breakout Signals - خودرو بانک
Aug Macro: Is Prime Medicine Inc. forming a breakout patternJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
What’s the profit margin of Prime Medicine Inc.Portfolio Performance Summary & Daily Stock Trend Watchlist - خودرو بانک
Will Prime Medicine Inc. bounce back from current supportJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
PRME.O Drops 5.8% on Technical Weakness Amid Mixed Peer Activity - AInvest
Prime Medicine (PRME.O) Faces Sharp Intraday Drop Despite No New Fundamental News - AInvest
Advanced analytics toolkit walkthrough for Prime Medicine Inc.Breakout Watch & Risk Controlled Stock Pick Alerts - Newser
Prime Medicine Inc Stock (PRME) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):